A carregar...
Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19
Current standard treatment of COVID-19 lacks in effective antiviral options. Plitidepsin, a cyclic depsipeptide authorized in Australia for patients with refractory multiple myeloma, has recently emerged as a candidate anti-SARS-CoV-2 agent. The aim of this review was to summarize current knowledge...
Na minha lista:
| Publicado no: | J Pers Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8306251/ https://ncbi.nlm.nih.gov/pubmed/34357135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11070668 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|